Patients with positive SOX12, Foxp3, CD11b, and CD163 expression or negative CD8 expression showed tumor‐aggressive tendency (Tables S5–S9, Supporting Information) and poor prognosis (Figure S14C; Table S10, Supporting Information). Here, CD163 is linked to neoplasm.